EP3937914

CANCER TREATMENT COMPRISING NALTREXONE AND A CANNABINOID

  • :
    EP einkaleyfi: Þýðing ekki lögð inn
  • :
    13.3.2020
  • :
    9.8.2023
  • :
    20712673.1
  • :
    12.3.2040
  • :
    CANCER TREATMENT COMPRISING NALTREXONE AND A CANNABINOID

13.3.2020
9.8.2023
  • :
    LDN Pharma Limited
  • :
    45 Gresham Street, London EC2V 7BG, GB
  • :
    LIU, Wai
  • :
    London EC2V 7BG, GB
  • :
    DALGLEISH, Angus
  • :
    London EC2V 7BG, GB
  • :
    201903546
  • :
    15.3.2019
  • :
    GB
  • :
    GB2020050638
  • :
    13.3.2020
  • :
    A61K 31/05, A61K 31/08, A61K 31/192, A61K 31/352, A61K 31/485, A61K 45/06, A61P 35/00, A61K 31/555, A61K 31/7068